GF
Gabelli Funds Portfolio holdings
AUM
$14.1B
1-Year Return
24.08%
This Quarter Return
+18.25%
1 Year Return
+24.08%
3 Year Return
+81.74%
5 Year Return
+169.49%
10 Year Return
+407.67%
AUM
$14B
AUM Growth
+$1.2B
(+9.4%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-5.92%
Top 10 Holdings %
Top 10 Hldgs %
11.68%
Holding
1,319
New
181
Increased
195
Reduced
495
Closed
102
Top Buys
| 1 |
NAV
Navistar International
NAV
|
$48.9M |
| 2 |
Morgan Stanley
MS
|
$28.2M |
| 3 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
$27.3M |
| 4 |
CrowdStrike
CRWD
|
$23M |
| 5 |
Freeport-McMoran
FCX
|
$21.5M |
Top Sells
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$73.1M |
| 2 |
Rollins
ROL
|
$48.6M |
| 3 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$39M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$37.7M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$29.8M |
Sector Composition
| 1 | Industrials | 17.96% |
| 2 | Communication Services | 12.15% |
| 3 | Utilities | 11.66% |
| 4 | Financials | 10.49% |
| 5 | Technology | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CKH
326
DELISTED
Seacor Holdings Inc.
CKH
| $10.1M | 0.07% |
+243,812
| New | +$10.1M |
|
327
Modine Manufacturing
MOD
$7.1B
| $10.1M | 0.07% |
804,000
+89,000
| +12% | +$1.12M |
|
328
Unilever
UL
$158B
| $9.89M | 0.07% |
163,900
+66,000
| +67% | +$3.98M |
|
329
Telus
TU
$25.3B
| $9.78M | 0.07% |
494,000
| – | – |
|
330
Intuitive Surgical
ISRG
$167B
| $9.69M | 0.07% |
35,520
+420
| +1% | +$115K |
|
331
AZZ Inc
AZZ
$3.51B
| $9.69M | 0.07% |
204,156
+6,000
| +3% | +$285K |
|
|
DBD
332
DELISTED
Diebold Nixdorf Incorporated
DBD
| $9.69M | 0.07% |
908,500
-25,500
| -3% | -$272K |
|
333
National Grid
NGG
$69.6B
| $9.66M | 0.07% |
182,486
-1,115
| -0.6% | -$59K |
|
|
VRTU
334
DELISTED
Virtusa Corporation
VRTU
| $9.63M | 0.07% |
188,313
+107,223
| +132% | +$5.48M |
|
335
Chemed
CHE
$6.79B
| $9.59M | 0.07% |
18,000
| – | – |
|
336
M&T Bank
MTB
$31.2B
| $9.48M | 0.07% |
74,450
-4,000
| -5% | -$509K |
|
337
Teladoc Health
TDOC
$1.38B
| $9.42M | 0.07% |
47,100
-200
| -0.4% | -$40K |
|
338
Ormat Technologies
ORA
$5.51B
| $9.31M | 0.07% |
103,150
| – | – |
|
339
Bausch Health
BHC
$2.72B
| $9.26M | 0.07% |
445,000
-62,500
| -12% | -$1.3M |
|
340
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $9.24M | 0.07% |
371,624
+9,224
| +3% | +$229K |
|
341
Weyerhaeuser
WY
$18.9B
| $9.21M | 0.07% |
274,700
-21,000
| -7% | -$704K |
|
342
Ashland
ASH
$2.51B
| $9.18M | 0.07% |
115,900
-8,000
| -6% | -$634K |
|
343
NiSource
NI
$19B
| $9.13M | 0.07% |
398,000
| – | – |
|
344
Novartis
NVS
$251B
| $9.07M | 0.06% |
96,000
-3,000
| -3% | -$283K |
|
345
Stryker
SYK
$150B
| $9.04M | 0.06% |
36,900
-2,000
| -5% | -$490K |
|
346
Molson Coors Class B
TAP
$9.96B
| $8.95M | 0.06% |
198,000
-10,000
| -5% | -$452K |
|
|
BEAT
347
DELISTED
BioTelemetry, Inc.
BEAT
| $8.91M | 0.06% |
123,631
+34,536
| +39% | +$2.49M |
|
348
Interactive Brokers
IBKR
$26.8B
| $8.91M | 0.06% |
584,996
-4,000
| -0.7% | -$60.9K |
|
349
AbbVie
ABBV
$375B
| $8.84M | 0.06% |
82,496
+16,900
| +26% | +$1.81M |
|
350
MSCI
MSCI
$42.9B
| $8.77M | 0.06% |
19,640
+240
| +1% | +$107K |
|